Research ArticleOriginal Research
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database
Hyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, Britney A Stottlemyer, Richard D Boyce and Sandra L Kane-Gill
Respiratory Care November 2021, 66 (11) 1739-1745; DOI: https://doi.org/10.4187/respcare.08809
Hyunwoo Kim
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
Colin M Pfeiffer
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
Matthew P Gray
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
Britney A Stottlemyer
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
Richard D Boyce
Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Sandra L Kane-Gill
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
In this issue
Respiratory Care
Vol. 66, Issue 11
1 Nov 2021
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database
Hyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, Britney A Stottlemyer, Richard D Boyce, Sandra L Kane-Gill
Respiratory Care Nov 2021, 66 (11) 1739-1745; DOI: 10.4187/respcare.08809
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database
Hyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, Britney A Stottlemyer, Richard D Boyce, Sandra L Kane-Gill
Respiratory Care Nov 2021, 66 (11) 1739-1745; DOI: 10.4187/respcare.08809